Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
The Native Antigen Company Ltd
The Native Antigen Company Ltd
Activities:
Ingredients
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Drug Delivery
The Native Antigen Company strengthens senior team to support growing product portfolio
Appointments of Business Development Manager and Senior Product Manager follow move to state-of-the-art new facilities at Oxford Technology Park
Research & Development
Native Antigen Company expands range of norovirus-like particles
Norovirus is a small non-enveloped, positive-sense RNA virus belonging to the Caliciviridae family. It is a major cause of non-bacterial acute gastroenteritis outbreaks
Ingredients
The Native Antigen Company introduces veterinary reagents
The range includes pathogens such as coronaviruses, Borrelia, Rift Valley fever virus, African swine fever virus, Toxocara and heartworm
Manufacturing
The Native Antigen Company launches SARS-CoV-2 antibodies
The introduction of these antibodies extends The Native Antigen Company’s existing range and offers researchers a source of reagents for research
Ingredients
The Native Antigen Company introduces custom service for influenza antigens
The reagent supplier has announced the introduction of its custom contract service to rapidly develop antigen panels for influenza A and B viruses
Research & Development
BBI Solutions partners to distribute COVID-19 antigens in China
The Native Antigen Company has agreed distribution rights with BBI to provide coronavirus reagents in China
Ingredients
The Native Antigen Company introduces novel coronavirus antigen
UK company has developed rapid response manufacturing capabilities to produce reagents for emerging epidemic diseases
Subscribe now